PSTV•benzinga•
Plus Therapeutics Reports Peer-Reviewed Publication Of Phase 1 Glioma Data; Rhenium (186Re) Obisbemeda Shows Safety, Response And Potential Efficacy For Glioblastoma Patients
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 7, 2025 by benzinga